AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 207 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,190,000 | +69.9% | 402,882 | +100.4% | 0.06% | -19.7% |
Q4 2018 | $3,054,000 | +16.7% | 201,048 | +167.3% | 0.08% | +65.2% |
Q4 2016 | $2,617,000 | -42.1% | 75,201 | -59.2% | 0.05% | -47.1% |
Q3 2016 | $4,518,000 | +30.8% | 184,326 | +24.9% | 0.09% | +24.3% |
Q1 2016 | $3,453,000 | -23.5% | 147,551 | -1.3% | 0.07% | -23.1% |
Q4 2015 | $4,514,000 | +93.2% | 149,531 | +154.3% | 0.09% | +89.6% |
Q3 2015 | $2,336,000 | +65.1% | 58,795 | +127.1% | 0.05% | +92.0% |
Q1 2015 | $1,415,000 | +350.6% | 25,894 | +251.7% | 0.02% | +316.7% |
Q4 2014 | $314,000 | -55.3% | 7,363 | -66.6% | 0.01% | -57.1% |
Q3 2014 | $703,000 | -89.7% | 22,041 | -92.2% | 0.01% | -89.0% |
Q4 2013 | $6,852,000 | +23.7% | 282,215 | +9.4% | 0.13% | +18.7% |
Q3 2013 | $5,538,000 | -8.2% | 257,880 | -4.9% | 0.11% | -13.0% |
Q2 2013 | $6,030,000 | – | 271,028 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |